WISCON Pharmaceuticals Private Ltd, a wholly subsidiary Company, too participated in the Pharma sector to harvest inherent potentials in India, having expertise in marketing of many therapeutic segments globally.
The manufacturing agreements have been finalized with a number of WHO GMP and ISO 9001 -2000 certified companies for certain specialized products and to leverage their expertise in bringing to the medical fraternity technologically superior products. Its product portfolio predominantly is in line around child’s Healthcare and allied products with its global vision. Additionally WISCON has its dominant presence in Family Physicians, Consulting Physicians, Gynae , surgery and anti malarial markets.The product formulations shall comprise Syrups/Drops, tablets, capsules, Nasal Sprays/Rubs and injectables .
WISCON’s strategy for growth is to enter the market to leverage its global expertise in pharmaceutical marketing with regional strategy and to bring about a proper synergy in marketing. WISCON has bought over the Brands marketed by a reputed Company in India having a strong portfolio in Child Care and allied products in line with WISCON's global portfolio . As a part of its organic and inorganic growth strategy this acquisition is a step towards attaining a leadership position in child care products in Indian market.
India as on date produces USD 10 Billion worth of medicines registering an exponential growth during the last six decades from a very nascent stage. The growth is highly significant but unfortunately the existing scenario does reflect that 60% of the population even today could not afford allopathic medicines. This is undoubtedly a hard fact even in presence of sustained country’s growth of economy and employment as against a rising population.
WISCON’S MISSION FOR INDIA IS TO ACCESS ITS PRODUCTS TO ALL THE PARTS OF THE COUNTRY INCLUDING RURAL AREAS WITH QUALITY AT AN AFFORDABLE PRICE .
THE VISION OF WISCON IS TO ATTAIN LEADERSHIP IN CHILDCARE PRODUCTS WITH A HIGH PROFILE OF IMAGE.